How to translate text using browser tools
1 October 2009 Epigenetic Treatment in Assisted Human Embryo Implantation
Hiroshi Uchida, Tetsuo Maruyama, Maki Kagami, Hideyuki Oda, Sayaka Nishikawa, Takashi Kajitani, Hironori Asada, Yasunori Yoshimura
Author Affiliations +
Abstract

Recent advances in assisted reproductive technologies (ART) have resulted in higher fertilization rates for infertile couples. However, successful pregnancy is prevented by failure of the embryo to implant in the endometrium. Human embryo implantation involves apposition and adhesion, followed by penetration through the endometrial epithelial layer and invasion of the embryo into the endometrial stroma. Human implantation is a multi-step event requiring the orchestrated regulation of endometrial cells, involving cell proliferation, differentiation, motility, and adhesion. Reversible histone acetylation affects functional protein expression by regulating gene transcription. Histone deacetylase inhibitors (HDACIs) can induce expression of specific proteins, thereby affecting cell function. At present, HDACIs are used in anticancer therapy to induce cancer cell apoptosis. In this review, we discuss the potential of HDACIs for supportive therapy of infertility caused by endometrial dysfunction, and introduce recent reports that HDACIs target and affect various cell functions.

Hiroshi Uchida, Tetsuo Maruyama, Maki Kagami, Hideyuki Oda, Sayaka Nishikawa, Takashi Kajitani, Hironori Asada, and Yasunori Yoshimura "Epigenetic Treatment in Assisted Human Embryo Implantation," Journal of Mammalian Ova Research 26(3), 116-121, (1 October 2009). https://doi.org/10.1274/jmor.26.116
Received: 13 February 2009; Accepted: 1 June 2009; Published: 1 October 2009
JOURNAL ARTICLE
6 PAGES

This article is only available to subscribers.
It is not available for individual sale.
+ SAVE TO MY LIBRARY

KEYWORDS
Glycodelin
HDACi
implantation
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top